Resources
58 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 5/12/2021 (updated 4/10/2024)
Drug overdose is a continuing epidemic that claimed the lives of over 67,000 Americans in 2018. Opioids, either alone or in combination with other substances, were responsible for approximately 70% of these deaths. Many of these lost lives and other opioid-related harms are preventable through the timely administration of the opioid reversal drug naloxone and, where appropriate, other follow-up care.
Posted 3/25/2021 (updated 4/5/2024)
Considerations for Addressing Neonatal Abstinence Syndrome (NAS)
Dr. Lopata, JBS NAS Technical Expert Leads, and NAS RCORP grantees from the Western Regions will discuss resources, stigma, best practices, and challenges in addressing NAS.
Posted 3/23/2021 (updated 4/5/2024)
This webinar provided an overview of the statute and regulations of 42 CFR, Part 2, the federal regulations for confidentiality of substance use records. It provided a brief history of the statute and its original purpose, and the three major revisions to the regulations. It covered the changes to the statute that were made as part of the CARES Act last year and its impact on providers. It covered the issue of applicability of the regulations as they have evolved over the three major revisions.
Posted 3/10/2021 (updated 4/5/2024)
This webinar provided the foundational information necessary to plan and implement effective anti-stigma strategies. We defined stigma and internalized stigma and their impact on vulnerable populations—drug policy, public perception, healthcare access. We then explored relevant resources, helpful tools, and connect with national organizations doing work in this space.
Posted 3/2/2021 (updated 4/4/2024)
In light of the accelerating and rapidly evolving overdose crisis in the United States (US), new strategies are needed to address the epidemic and to efficiently engage and retain individuals in care for opioid use disorder (OUD). Moreover, there is an increasing need for novel approaches to using health data to identify gaps in the cascade of care for persons with OUD.
Posted 2/17/2021 (updated 4/4/2024)
This packet presents you with the tools, materials and resources necessary to kick off grant activities quickly and efficiently.
Posted 2/3/2021 (updated 4/4/2024)
This link will direct you to the Regional Telehealth Resource Centers homepage. The resource centers provide toolkits, checklists, training videos, webinars, reports and issue briefs, forums and other events focused on “expanding the reach of healthcare and sustainable telehealth programs in local, rural, and underserved communities for the most vulnerable populations and tailored for your region.
Posted 12/23/2020 (updated 4/4/2024)
This article presents an important look into stigma of families impacted by NAS and the ways in which healthcare providers must work to combat stigma’s harmful effects, and explores directions for future research of strategies for reducing stigma amongst this population to improve engagement in healthcare and positive heath-seeking behaviors. The authors reported that mothers of infants with NAS experience intensified stigma surrounding SUDs and the challenge of overcoming exclusion, shame, and judgement of their ability to parent. In examining nurses’ perceptions of perinatal women with SUD, the authors found that many struggled with negative attitudes and prejudices towards mothers of infants with NAS that interfered with their ability to provide nonjudgmental care. The authors urge nurses to implement substantial strategies for addressing stigma through tools such as the ACTS script.
Posted 5/12/2020 (updated 4/3/2024)
A Tool for Improving The Recruitment and Retention of Critical Access Hospital and Community Health Center Physicians
Posted 8/19/2021 (updated 4/2/2024)
Addiction Policy Forum, in partnership with Justice Community Opioid Innovation Network (JCOIN) and the National Judicial Task Force to Examine State Courts’ Response to Mental Illness, have released a new online course to help educate judges and court staff on the FDA-approved medications to treat opioid use disorder and their effectiveness for people involved with the criminal justice system.
The course is self-paced and takes approximately 30 minutes to complete. The course aims to prepare participants with the knowledge and information about what substance use disorder treatment involves, the differences between the types of medications used to treat opioid use disorder, and how those medications work.